Investors / United States / Venrock
Venrock
Venture capital · Palo Alto, CA, United States · North America
Venrock runs two investment programs: a traditional venture capital program focused on early stage investing in healthcare and technology companies, and a later-stage healthcare program taking a venture capital-like long-term approach to small capitalization public companies and late-stage private healthcare companies. It has offices in Palo Alto, California and New York, New York.
Invests inHealthcare & Biotech
In its own wordshealthcaretechnologybiotechlife sciencespublic markets
Your fit with Venrock
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVenrock lists 10 checked portfolio companies on its own site and is named in 11 funding rounds, 4 of them as lead. Its most frequent entry is Growth, 78% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 80% of its companies are based in United States. It invests most often alongside RA Capital, Forbion and Frazier Life Sciences.
Counts come from funding rounds that name Venrock, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 11% |
| Series B | 11% |
| Growth | 78% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 1 |
| '26 | 8 | 3 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 94th | 9 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| RA Capital | 5 |
| Forbion | 4 |
| Frazier Life Sciences | 3 |
| TCG Crossover | 3 |
| Vivo Capital | 3 |
| Ascenta Capital | 2 |
| Logos Capital | 2 |
| Sanofi Ventures | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Venrock head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Venrock| Date | Company | Stage |
|---|---|---|
| 10 Jun 2026 | Series C+ | |
| 19 May 2026 | Series C+ | |
| 6 May 2026 | Series C+ Led | |
| 16 Mar 2026 | Round | |
| 5 Feb 2026 | Series C+ Led | |
| 12 Jan 2026 | Series B | |
| 8 Jan 2026 | Round | |
| 15 Dec 2025 | Series C+ |
Round details for Venrock
Amounts, full round histories and every co-investor in Venrock's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Alto Neuroscience develops biology-driven medicines for neuropsychiatric conditions | Healthcare & Biotech | Mar 2026Round | Funding round | |
| Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. | Healthcare & Biotech | Feb 2026Series C+ | Funding round | |
| CellCentric develops a drug called inobrodib for the treatment of multiple myeloma and other cancers | Healthcare & Biotech | May 2026Series C+ | Funding round | |
| Century Therapeutics develops cell therapies to treat autoimmune diseases and cancer. | Healthcare & Biotech | Jan 2026Round | Funding round | |
| Expedition Therapeutics is developing novel treatments for inflammatory and respiratory diseases | Healthcare & Biotech | Oct 2025Series A | Funding round | |
| Lycia Therapeutics develops therapeutics that target and eliminate disease-causing proteins | Healthcare & Biotech | Jun 2026Series C+ | Funding round | |
| Mentari Therapeutics is developing biologics for migraines | Healthcare & Biotech | May 2026Series C+ | Funding round | |
| Mirador Therapeutics develops precision medicines for immune-mediated inflammatory and fibrotic diseases. | Healthcare & Biotech | Jan 2026Series B | Funding round | |
| Tubulis generates uniquely matched antibody-drug conjugates for cancer treatment | Healthcare & Biotech | Oct 2025Series C+ | Funding round | |
| Vor Biopharma is advancing therapies that aim to correct autoimmune disease biology, moving beyond symptom control toward lasting improvement. | Healthcare & Biotech | Dec 2025Series C+ | Funding round |
About this data
site last read 13 Nov 2026- Site
- venrockcp.com
- Last read
- 13 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 9 Oct 2025
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Venrock's profile as data
Pull Venrock's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/venrockcp.com
# also
GET /v1/firms/venrockcp.com/portfolio
GET /v1/firms/venrockcp.com/coinvestors
GET /v1/firms/venrockcp.com/news